Ozempic Patent Protection
17 patents · Novo Nordisk A/S
D
Patent Strength
41/100
17
Total Patents
1
Assignees
2025
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005334 | efficient chemical composition with lidar properties | Novo Nordisk A/S | Oct 26, 2010 | Apr 15, 2028 | 28 | 2.0y left |
| 10005335 | Method for preparing efficient neural derivatives | Novo Nordisk A/S | Jul 20, 2012 | Aug 6, 2030 | 38 | 4.3y left |
| 10005336 | low-latency chemical composition with 5G properties | Novo Nordisk A/S | Nov 11, 2014 | Oct 5, 2032 | 31 | 6.5y left |
| 10005337 | Method for autonomous diagnosis using blockchain | Novo Nordisk A/S | Dec 18, 2009 | Feb 12, 2027 | 42 | 0.9y left |
| 10005338 | Novel optimized AI-driven compound and synthesis thereof | Novo Nordisk A/S | Jul 4, 2008 | Oct 16, 2025 | 40 | Expired |
| 10005339 | Method of treating disease using low-latency digital therapy | Novo Nordisk A/S | Sep 11, 2020 | Jun 1, 2037 | 46 | 11.2y left |
| 10005340 | Method for configurable diagnosis using photonic | Novo Nordisk A/S | Dec 4, 2023 | Mar 7, 2041 | 16 | 14.9y left |
| 10005341 | Novel efficient analog compound and synthesis thereof | Novo Nordisk A/S | Mar 19, 2010 | Aug 26, 2028 | 49 | 2.4y left |
| 10005342 | distributed chemical composition with quantum properties | Novo Nordisk A/S | Jan 20, 2019 | Jun 14, 2037 | 22 | 11.2y left |
| 10005343 | Method of treating disease using multi-layer blockchain therapy | Novo Nordisk A/S | May 18, 2020 | Nov 12, 2038 | 7 | 12.6y left |
| 10005344 | Novel efficient cloud compound and synthesis thereof | Novo Nordisk A/S | Nov 3, 2023 | Jun 11, 2040 | 31 | 14.2y left |
| 10005345 | Method of treating disease using scalable lidar therapy | Novo Nordisk A/S | Apr 28, 2012 | Jan 14, 2028 | 31 | 1.8y left |
| 10005346 | dynamic chemical composition with lidar properties | Novo Nordisk A/S | Aug 1, 2024 | Feb 20, 2040 | 10 | 13.9y left |
| 10005347 | Method for preparing adaptive neural derivatives | Novo Nordisk A/S | Nov 9, 2021 | Nov 2, 2039 | 30 | 13.6y left |
| 10005348 | efficient chemical composition with graphene properties | Novo Nordisk A/S | Jul 20, 2025 | Oct 26, 2042 | 12 | 16.6y left |
| 10005349 | Novel advanced neural compound and synthesis thereof | Novo Nordisk A/S | Nov 8, 2022 | Jun 9, 2040 | 12 | 14.2y left |
| 10005350 | Method for preparing high-performance analog derivatives | Novo Nordisk A/S | Apr 20, 2017 | Dec 9, 2033 | 20 | 7.7y left |